The Efficacy of Psilocybin Therapy for Depression in Parkinson's Disease
The purpose of this study is to understand whether people with Parkinson's Disease and depression have improvement in their symptoms after psilocybin therapy.
- Record type
- Registered clinical trial
- Status
- recruiting
- Phase
- Phase 2
- Institution
- Yale University
- Principal investigator
- Sophie Holmes, PhD
- Start date
- 2026-07-01
- End date
- 2030-07-01
- Registry ID
- NCT07610369
Listed in the DMT Code trials, studies and experiments observatory. Record type: Registered clinical trial. Only registered clinical trials carry clinical authority in this record set.